Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate vs Normal Saline Catheter Lock Solution in Hemodialysis
NCT03627884Phase 4Completed
- Sponsor
- NYC Health + Hospitals/South Brooklyn Health
- Start
- Oct 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of sodium bicarbonate in catheter-related thrombosis (CRT) and catheter-related bloodstream infection (CRBSI) (2 arms), sponsored by NYC Health + Hospitals/South Brooklyn Health. Primary endpoints: Lumen Clot Formation at 18 months, Catheter Related Infection at 18 months and 2 more. Started Oct 2016; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
catheter-related thrombosis (CRT)catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT03627884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03627884.